(Q39312152)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22810956%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Gene expression-based chemical genomics identifies heat-shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22810956%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

0 references

1 reference

ChEBI release 2020-05-28

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22810956%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Chun-Yu Liu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22810956%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Ming-Huang Chen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22810956%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Wu-Lung R Yang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22810956%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Ya-Wen Kao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22810956%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Tsung-Wen Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22810956%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Shu-Chaou Chao

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22810956%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Peter Mu-Hsin Chang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22810956%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Cheng-Hwai Tzeng

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22810956%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Yee Chao

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22810956%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Ming-Han Chen

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22810956%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Chun-Nan Yeh

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22810956%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Chi-Ying F Huang

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22810956%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

English

0 references

publication date

18 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22810956%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22810956%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22810956%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22810956%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

293-303

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22810956%20AND%20SRC:MED&resulttype=core&format=json

Cholangiocarcinoma: update and future perspectives.

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Cholangiocarcinoma: a compact review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

The epidemiology of cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Genetics of biliary tract cancers and emerging targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Development of molecularly targeted therapies in biliary tract cancers: reassessing the challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Gene expression-based chemical genomics identifies potential therapeutic drugs in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Transcript profiling and RNA interference as tools to identify small molecule mechanisms and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Targeting the dynamic HSP90 complex in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Identification of osteopontin as the most consistently over-expressed gene in intrahepatic cholangiocarcinoma: detection by oligonucleotide microarray and real-time PCR analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Characterization of a novel rat cholangiocarcinoma cell culture model-CGCCA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Animal PET for thioacetamide-induced rat cholangiocarcinoma: a novel and reliable platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Herceptin raises its sights beyond advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

KRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer: a phase I dose-escalation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Requirement of Hsp90 activity for IkappaB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Mechanistic evaluation of the novel HSP90 inhibitor NVP-AUY922 in adult and pediatric glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743

Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27743